Trial Profile
A randomized study to evaluate the efficacy of Filgrastim and Pegfilgrastim as an add-on therapy to R-CHOP in patients with diffuse large B-cell lymphoma (DLBCL)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Sep 2015
Price :
$35
*
At a glance
- Drugs Filgrastim (Primary) ; Pegfilgrastim (Primary) ; Cyclophosphamide; Doxorubicin; Prednisone; Rituximab; Vincristine
- Indications Diffuse large B cell lymphoma
- Focus Therapeutic Use
- 07 Sep 2015 New trial record